Oncternal Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Oncternal Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -131 %, a 73.8% decline year-over-year.
  • Oncternal Therapeutics, Inc. annual Return On Assets for 2023 was -83.6 %, a 47.5% decline from 2022.
  • Oncternal Therapeutics, Inc. annual Return On Assets for 2022 was -56.7 %, a 88.2% decline from 2021.
  • Oncternal Therapeutics, Inc. annual Return On Assets for 2021 was -30.1 %, a 21.8% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -131 -55.8 -73.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -108 -40.5 -59.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -91 -26.7 -41.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -83.6 -26.9 -47.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -75.5 -27 -55.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -67.7 -24.1 -55.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -64.3 -27.9 -76.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -56.7 -26.6 -88.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -48.5 -25.1 -107% Jul 1, 2022 Sep 30, 2022
Q2 2022 -43.6 -21.1 -93.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -36.4 -9.62 -35.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -30.1 +8.38 +21.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -23.4 +68.5 +74.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -22.6 +70 +75.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -26.8 +127 +82.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -38.5 +97.8 +71.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -91.9 +49.1 +34.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -92.6 +19.5 +17.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -154 -117 -323% Jan 1, 2020 Mar 31, 2020
Q4 2019 -136 -105 -338% Oct 1, 2019 Dec 31, 2019
Q3 2019 -141 -105 -294% Jul 1, 2019 Sep 30, 2019
Q2 2019 -112 -65 -138% Apr 1, 2019 Jun 30, 2019
Q1 2019 -36.3 +32.2 +47% Jan 1, 2019 Mar 31, 2019
Q4 2018 -31.1 +59.3 +65.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -35.8 +63.5 +63.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 -47.1 +98 +67.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -68.4 +60.1 +46.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -90.4 -10.7 -13.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -99.2 -40.8 -69.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -145 -239 -255% Apr 1, 2017 Jun 30, 2017
Q1 2017 -129 -87.5 -213% Jan 1, 2017 Mar 31, 2017
Q4 2016 -79.7 -32.2 -67.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 -58.4 +9.75 +14.3% Jul 1, 2016 Sep 30, 2016
Q2 2016 93.5 +278 Apr 1, 2016 Jun 30, 2016
Q1 2016 -41.1 +61 +59.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 -47.5 +92.5 +66.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 -68.2 +100 +59.5% Jul 1, 2015 Sep 30, 2015
Q2 2015 -185 -16.1 -9.54% Apr 1, 2015 Jun 30, 2015
Q1 2015 -102 +49.9 +32.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -140 +4.84 +3.34% Oct 1, 2014 Dec 31, 2014
Q3 2014 -168 -54.8 -48.2% Jul 1, 2014 Sep 30, 2014
Q2 2014 -168 -109 -183% Apr 1, 2014 Jun 30, 2014
Q1 2014 -152 -103 -211% Jan 1, 2014 Mar 31, 2014
Q4 2013 -145 -103 -243% Oct 1, 2013 Dec 31, 2013
Q3 2013 -114 -74.7 -192% Jul 1, 2013 Sep 30, 2013
Q2 2013 -59.6 -2.8 -4.93% Apr 1, 2013 Jun 30, 2013
Q1 2013 -48.9 +2.06 +4.04% Jan 1, 2013 Mar 31, 2013
Q4 2012 -42.2 Oct 1, 2012 Dec 31, 2012
Q3 2012 -39 Jul 1, 2012 Sep 30, 2012
Q2 2012 -56.8 Apr 1, 2012 Jun 30, 2012
Q1 2012 -51 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.